User: Guest  Login
Title:

Targeting ErbB Receptors in High-Grade Glioma.

Document type:
Journal Article
Author(s):
Berezowska, S; Schlegel, J
Abstract:
High-grade gliomas, including glioblastoma, are among the most malignant and treatment-refractory human neoplasms. The tumors show high levels of resistance to conventional therapies (i.e. surgery, irradiation, and chemotherapy), and despite treatment advances patient outcome remains poor. New therapeutic options are needed. An especially interesting idea is the rational development of new therapies targeting molecules in cancer specific signaling pathways, thereby ideally increasing treatment e...     »
Journal title abbreviation:
Curr Pharm Des
Year:
2011
Journal volume:
17
Journal issue:
23
Pages contribution:
2468-87
Language:
eng
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/21827413
Print-ISSN:
1381-6128
TUM Institution:
Institut für Allgemeine Pathologie und Pathologische Anatomie
 BibTeX